Shares Outstanding Shares Outstanding n/a Close	2.41M
Shares Change (YoY) Shares Change (YoY) n/a Close	-0.19%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	-0.19%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	8.27%
Shares Floating Shares Floating n/a Close	n/a
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	392,910
FTD / Avg. Volume FTD / Avg. Volume n/a Close	59.93%

Short Selling Information

The latest short interest is 288.44K, so 15% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	288.44K
Short % of Shares Out Short % of Shares Out n/a Close	15%
Short % of Float Short % of Float n/a Close	19.6%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1

Valuation Ratios

The PE ratio is -23.05 and the forward PE ratio is -1.23. HCW Biologics's PEG ratio is -2.31.

PE Ratio PE Ratio n/a Close	-23.05
Forward PE Forward PE n/a Close	-1.23
PS Ratio PS Ratio n/a Close	269.62
Forward PS Forward PS n/a Close	90.9
PB Ratio PB Ratio n/a Close	-102.22
P/FCF Ratio P/FCF Ratio n/a Close	-47.76
PEG Ratio PEG Ratio n/a Close	-2.31

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for HCW Biologics.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 0.19, with a Debt / Equity ratio of -2.02.

Current Ratio Current Ratio n/a Close	0.19
Quick Ratio Quick Ratio n/a Close	0.19
Debt / Equity Debt / Equity n/a Close	-2.02
Debt / EBITDA Debt / EBITDA n/a Close	-0.49
Debt / FCF Debt / FCF n/a Close	-0.95
Interest Coverage Interest Coverage n/a Close	-25.45

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$71,299.78
Profits Per Employee Profits Per Employee n/a Close	$-833,994.83
Employee Count Employee Count n/a Close	36
Asset Turnover Asset Turnover n/a Close	0.08
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by -84.69% in the last 52 weeks. The beta is 0.83, so HCW Biologics's price volatility has been higher than the market average.

Beta Beta n/a Close	0.83
52-Week Price Change 52-Week Price Change n/a Close	-84.69%
50-Day Moving Average 50-Day Moving Average n/a Close	8.5
200-Day Moving Average 200-Day Moving Average n/a Close	15.69
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	36.95
Average Volume (20 Days) Average Volume (20 Days) n/a Close	655,566

Income Statement

In the last 12 months, HCW Biologics had revenue of 2.57M and earned -30.02M in profits. Earnings per share was -0.77.

Revenue Revenue n/a Close	2.57M
Gross Profit Gross Profit n/a Close	959.4K
Operating Income Operating Income n/a Close	-29.48M
Net Income Net Income n/a Close	-30.02M
EBITDA EBITDA n/a Close	-27.68M
EBIT EBIT n/a Close	-28.87M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-0.77

Full Income Statement

Balance Sheet

The company has 4.67M in cash and 13.69M in debt, giving a net cash position of -9.02M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	4.67M
Total Debt Total Debt n/a Close	13.69M
Net Cash Net Cash n/a Close	-9.02M
Retained Earnings Retained Earnings n/a Close	-100.56M
Total Assets Total Assets n/a Close	26.29M
Working Capital Working Capital n/a Close	-25.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.23M and capital expenditures -261.62K, giving a free cash flow of -14.49M.

Operating Cash Flow Operating Cash Flow n/a Close	-14.23M
Capital Expenditures Capital Expenditures n/a Close	-261.62K
Free Cash Flow Free Cash Flow n/a Close	-14.49M
FCF Per Share FCF Per Share n/a Close	-0.37

Full Cash Flow Statement

Margins

Gross margin is 37.38%, with operating and profit margins of -1148.5% and -1169.7%.

Gross Margin Gross Margin n/a Close	37.38%
Operating Margin Operating Margin n/a Close	-1148.5%
Pretax Margin Pretax Margin n/a Close	-1169.7%
Profit Margin Profit Margin n/a Close	-1169.7%
EBITDA Margin EBITDA Margin n/a Close	-1078.43%
EBIT Margin EBIT Margin n/a Close	-1148.5%
FCF Margin FCF Margin n/a Close	-564.48%

Dividends & Yields

HCWB does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for HCWB is $35, which is 444.3% higher than the current price. The consensus rating is "Buy".

Price Target Price Target n/a Close	$35
Price Target Difference Price Target Difference n/a Close	444.3%
Analyst Consensus Analyst Consensus n/a Close	Buy
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Apr 11, 2025. It was a backward split with a ratio of 1:40.

Last Split Date Last Split Date n/a Close	Apr 11, 2025
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:40

Scores

Altman Z-Score Altman Z-Score n/a Close	-9.28
Piotroski F-Score Piotroski F-Score n/a Close	2